MacroGenics Inc. buy Marianka
Start price
13.07.22
/
50%
€3.62
Target price
13.07.23
€7.00
Performance (%)
-8.29%
End price
02.08.22
€3.32
Summary
This prediction ended on 02.08.22 with a price of €3.32. With a performance of -8.29%, the BUY prediction for MacroGenics Inc. by Marianka closed slightly in the red. Marianka has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MacroGenics Inc. | -1.673% | -1.673% | -6.073% |
| iShares Core DAX® | -1.226% | 2.804% | 14.933% |
| iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% |
| iShares Nikkei 225® | -1.132% | -2.218% | 5.361% |
| iShares S&P 500 | -0.980% | 1.883% | 22.727% |
According to Marianka what are the pros and cons of MacroGenics Inc. for the foreseeable future?
Pros
Standard Investments for future growth
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Very capable Management
Good culture
Innovative
Some uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is important
Top 10 in its market
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Stable Large shareholder and/or long term investor
Medium risks for its business
Cons
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Risky balance sheet